Cure My Disease

Don't miss your cure!

 Log in / Sign up

New pill could regrow hair in severe alopecia – trial begins

NCT ID NCT07617597

Recruiting now Disease control Sponsor: Sun Pharma Japan Limited Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 3 times

Summary

This study tests a drug called deuruxolitinib in Japanese adults aged 18-65 with severe alopecia areata, an autoimmune condition causing significant scalp hair loss. Participants must have at least 50% hair loss. The trial measures how well the drug regrows hair and how satisfied patients are with their hair. It is a Phase 3, placebo-controlled study with an open-label extension, meaning all participants can receive the drug later.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alopecia alopecia areata

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALOPECIA AREATA

Contacts and locations

Locations

  • Study Site 101

    NOT_YET_RECRUITING

    Hamamatsu, 431-3192, Japan

  • Study Site 102

    NOT_YET_RECRUITING

    Asahikawa, 078-8510, Japan

  • Study Site 103

    RECRUITING

    Sapporo, 060-8648, Japan

  • Study Site 104

    RECRUITING

    Niigata, 951-8520, Japan

  • Study Site 105

    NOT_YET_RECRUITING

    Shinjuku-Ku, 160-0023, Japan

  • Study Site 106

    RECRUITING

    Mitaka-shi, 181-8611, Japan

  • Study Site 107

    NOT_YET_RECRUITING

    Kyoto, 606-8507, Japan

  • Study Site 108

    RECRUITING

    Osaka, 545-0051, Japan

  • Study Site 109

    RECRUITING

    Osaka, 542-0081, Japan

  • Study Site 110

    NOT_YET_RECRUITING

    Kurashiki, 701-0192, Japan

  • Study Site 111

    NOT_YET_RECRUITING

    Ube, 755-8505, Japan

  • Study Site 112

    NOT_YET_RECRUITING

    Kitakyushu, 807-8556, Japan

  • Study Site 113

    NOT_YET_RECRUITING

    Kurume, 830-0011, Japan

  • Study Site 114

    NOT_YET_RECRUITING

    Miyagi-gun, 981-0112, Japan

  • Study Site 116

    NOT_YET_RECRUITING

    Ishikawa, 920-0293, Japan

  • Study Site 117

    NOT_YET_RECRUITING

    Bunkyō City, 113-8431, Japan

  • Study Site 118

    NOT_YET_RECRUITING

    Kōtoku, 136-0075, Japan

  • Study Site 119

    NOT_YET_RECRUITING

    Ebina, 243-0432, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.